Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Stroke ; 51(2): 431-439, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31795898

RESUMO

Background and Purpose- Delayed cerebral infarction (DCI) is an important cause of morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage (aSAH). Stereotactic catheter ventriculocisternostomy (STX-VCS) and fibrinolytic/spasmolytic lavage is a new method for DCI prevention. Here, we assess the effects of implementing STX-VCS in an unselected aSAH patient population of a tertiary referral center. Methods- Retrospective cohort study of all consecutive aSAH patients admitted to a neurosurgical referral center during a 7-year period (April 2012 to April 2019). Midterm STX-VCS was introduced and offered to patients at high risk for DCI. We compared the incidence and burden of DCI, neurological outcome, and the use of induced hypertension and endovascular rescue therapy in this consecutive aSAH population 3.5 years before versus 3.5 years after STX-VCS became available. Results- Four hundred thirty-six consecutive patients were included: 222 BEFORE and 214 AFTER. Fifty-seven of 214 (27%) patients received STX-VCS. Stereotactic procedures resulted in one (2%) subdural hematoma. Favorable neurological outcome at 6 months occurred in 118 (53%) patients BEFORE and 139 (65%) patients AFTER (relative risk, 0.79 [95% CI, 0.66-0.95]). DCI occurred in 40 (18.0%) patients BEFORE and 17 (7.9%) patients AFTER (relative risk, 0.68 [95% CI, 0.57-0.86]), and total DCI volumes were 8933 (100%) and 3329 mL (36%), respectively. Induced hypertension was used in 97 (44%) and 30 (15%) patients, respectively (relative risk, 0.55 [95% CI, 0.46-0.65]). Thirty (13.5%) patients BEFORE versus 5 (2.3%) patients AFTER underwent endovascular rescue therapies (relative risk, 0.17 [95% CI, 0.07-0.42]). Conclusions- Selecting high-risk patients for STX-VCS reduced the DCI incidence, burden, and related mortality in a consecutive aSAH patient population. This was associated with an improved neurological outcome.


Assuntos
Infarto Cerebral/prevenção & controle , Fibrinolíticos/administração & dosagem , Hemorragia Subaracnóidea/terapia , Vasodilatadores/administração & dosagem , Ventriculostomia/métodos , Idoso , Aneurisma Roto , Infarto Cerebral/etiologia , Feminino , Humanos , Aneurisma Intracraniano , Masculino , Pessoa de Meia-Idade , Nimodipina/administração & dosagem , Seleção de Pacientes , Estudos Retrospectivos , Técnicas Estereotáxicas , Hemorragia Subaracnóidea/complicações , Irrigação Terapêutica/métodos , Ativador de Plasminogênio Tipo Uroquinase/administração & dosagem , Vasoespasmo Intracraniano/etiologia , Vasoespasmo Intracraniano/terapia
3.
J Neurosurg ; 105(3): 465-7, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16961144

RESUMO

In patients with intracerebal hemorrhage, cardiac dysfunction is a common phenomenon. Tako-tsubo cardiomyopathy is characterized by complete reversibility and therefore may constitute an entity with a favorable outcome. In this case report the authors describe a previously healthy 23-year-old man with no history of cardiac disease who suffered a severe fourth ventricular hemorrhage due to an angioma of the vermis cerebelli. After emergency surgery, progressive tachycardia, fibrillation, and electromechanical decoupling developed in the patient. An echocardiogram revealed left ventricular apical akinesia and basal hyperkinesis characteristic of tako-tsubo cardiomyopathy. One week after admission, cardiac function was normal. Tako-tsubo cardiomyopathy differs from common cardiac dysfunction in its reversible nature. This characteristic must be taken into consideration when treating patients with intracerebral hemorrhage to avoid misclassification of the disease.


Assuntos
Cardiomiopatias/complicações , Hemorragia Cerebral/complicações , Adulto , Neoplasias Encefálicas/complicações , Cardiomiopatias/diagnóstico , Cardiomiopatias/fisiopatologia , Hemorragia Cerebral/cirurgia , Ecocardiografia , Hemangioma/complicações , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA